AdipoGen Life Sciences

IL-35 (human):Fc (LALA-PG)-KIH (human) (rec.)

CHF 440.00
In stock
AG-40B-0252-C05050 µgCHF 440.00
More Information
Product Details
Synonyms Interleukin-35 (human):Fc Knobs-into-Holes (human) (rec.); IL-12 Subunit α; EBI3; Interleukin-27 Subunit β; Ebi3; Epstein-Barr Virus-induced Gene 3 Protein Homolog
Product Type Protein
Source/Host HEK 293 cells. Produced using animal component-free medium.

IL-12Ap35 (aa 23-219) (human):Fc (LALA-PG) Knobs and IL-27B/EBI3 (aa 21-229) (human):Fc (LALA-PG) Holes form the IL-35 (human):Fc (LALA-PG)-KIH (human) (rec.) using the Knobs-into-Holes technology (see reference: J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)).

Crossreactivity Human

Binds to human IL-35 receptor complex. Fc (LALA-PG)-KIH (human) does not bind to FcRs.

MW ~68kDa and 60 kDa (SDS-PAGE)
Purity ≥95% (SDS-PAGE)
Endotoxin Content <0.005 EU/μg purified protein (LAL test).
Concentration 1mg/ml after reconstitution.
Reconstitution Reconstitute with 50μl endotoxin-free water.
Accession Number P29459 / Q14213
Formulation Lyophilized. Contains PBS
Protein Negative Control

Fc (LALA-PG)-KIH (human) IgG1 Control (rec.) (Prod. No. AG-35B-0018)

Other Product Data

UniProt link P29459IL-12A (human)

UniProt link Q14213IL-27B /Ebi3 (human)

Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After reconstitution, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Centrifuge lyophilized vial before opening and reconstitution.
PBS containing at least 0.1% BSA should be used for further dilutions.
Use/Stability Stable for at least 6 months after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF

Interleukin-12 (IL-12) family members are heterodimer glycoproteins, composed of two covalently linked subunits, α and β chains. The α-subunit consists of IL-23p19, IL-27p28, and IL-12p35 and the β-subunit includes IL-12p40 and Epstein-Barr virus-induced gene (Ebi3). IL-12 members bind to cognate heterodimeric receptor chains expressed on T cells.

This family includes IL-12, IL-23, IL-27 and IL-35 and IL-39. IL-12 and IL-23 are predominantly proinflammatory cytokines that contribute key roles in the development of Th1 and Th17 cells, respectively. IL-27 has both pro- and anti-inflammatory properties and is a potent T cell immunomodulator. IL-35, a new member of this family, is a potent inhibitory cytokine produced by natural, thymus-derived regulatory T cell (nTreg) populations. Recently, a subset of B cells that produce IL-35 was identified and shown to provide protection against autoimmune diseases. These IL-12 family members link innate immunity with the development of adaptive immunity and are also important for regulating T cell responses.

IL-35 is composed of two subunits, IL-12A and Epstein-Barr virus-induced gene 3 (EBI3) signals via a heterodimeric receptor consisting of IL-12Rβ2 and glycoprotein (gp130), leading to activation of STAT 1 and 4. IL-35 is a potent suppressive cytokine directly limiting the inflammatory response that has important roles in infection, cancer and autoimmune diseases.

The protein IL-35 (human):Fc (LALA-PG)-KIH (human) (rec.) is produced by using two different vectors, one encoding for the IL-12A:Fc Knobs sequence (synthesizing a protein of 68kDa) and one encoding for the IL27B/EBI3:Fc Holes sequence (synthesizing a protein of 60kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology; J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)) required for dimerization and for secretion of the final protein IL-35 (human):Fc (LALA-PG)-KIH (human) (rec.). The LALA-PG mutations inhibit binding to FcγRs and C1q while FcRn binding and Fc stability remain unaffected.

InVivoKines™ are a new generation of recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed and manufactured by AdipoGen Life Sciences.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.